3 hours ago - The FDA approves Wegovy, the first oral GLP-1 pill, offering a new weight loss solution for those struggling with obesity and overweight.

1 week ago - The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk announced the approval of its oral Wegovy pill, an oral semaglutide medication, in a news release Monday.

In this trial, those randomized to receive the highest approved dosage of Zepbound (15 mg once weekly) lost on average 18% of their body weight compared to those randomized to placebo.

1 week ago - Instead of weekly injections, patients will soon be able to swallow a daily pill to lose weight. Novo Nordisk's pill form of Wegovy is the first to gain Food and Drug Administration approval.

1 hour ago - The semaglutide (Wegovy; Novo Nordisk) pill offers patients a noninjectable alternative with weight loss efficacy comparable to the original injectable formulation, expanding access to GLP-1 therapy for millions of US adults living with obesity ...

1-800-FDA-1088. This site is intended for US patients only. Back to top · About Wegovy · Now Approved—Wegovy® pill · Managing Weight With Wegovy® · How Wegovy® Works for Weight Loss · Cardiovascular Risk Reduction · Adolescents & the Wegovy® Pen ·

1 week ago - The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs.

1 week ago - The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.

1 day ago - Beginning in January 2026, this pill - developed by Danish pharmaceutical company Novo Nordisk - will become a daily option for adults with obesity or overweight who are looking to lose weight alongside diet and exercise, while also helping ...

1 week ago - The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive approval from the regulator, marking a new era ...

1 week ago - Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The FDA's approval handed drugmaker Novo Nordisk an ...

1 day ago - MONDAY, Dec. 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the once-daily Wegovy (semaglutide) pill to help adults with obesit

1 week ago - Health regulators have approved the first pill form of the blockbuster drug Wegovy, providing patients with a new option for weight loss and management that eliminates the need for regular injections.

1 day ago - The FDA's approval of the Wegovy pill represents the first oral GLP-1 medication cleared specifically for weight loss. According to Novo Nordisk's announcement and independent reporting: ... According to the published clinical trial data in ...

“It’s the kind of weight loss you'd expect with some types of bariatric surgery.” Zepbound, medication that mimics two hormones, wins FDA approval.

1 week ago - The FDA's approval also clears the pill for use to reduce the risk of major cardiovascular events, such as death, heart attack or stroke, in adults with obesity and established cardiovascular disease, according to Novo Nordisk. That's consistent with the approval label of the company's blockbuster weight loss drug Wegovy, which shares the same active ingredient, semaglutide.

Currently, both Novo Nordisk, which manufactures Ozempic and Wegovy, and Eli Lilly, which manufactures Mounjaro and Zepbound, are preparing new, daily GLP-1 pills for FDA approval. Novo's new GLP-1 pill is an oral formulation of semaglutide, the main ingredient in Ozempic and Wegovy.

1 week ago - With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,” Novo Nordisk CEO Mike Doustdar says in a Dec.